Navigation Links
DOE Labs Take Pride in Award-Winning IBM Blue Gene Series
Date:10/7/2009

Argonne, Lawrence Livermore helped design supercomputer honored by President Obama

Argonne, Ill. (Vocus) October 7, 2009 -- The IBM Blue Gene series of energy-efficient supercomputers, central to breakthrough scientific research around the world, will be singled out by President Barack Obama as a Medal of Technology and Innovation award-winner on October 7 in Washington, D.C.

When IBM accepts this well-deserved honor, computer scientists at the U.S. Department of Energy's (DOE) Argonne and Lawrence Livermore national laboratories can take pride in their role in making these computers a reality. Both sites contributed critical input and software components through a DOE research and development partnership with IBM that strongly impacted Blue Gene's extreme-scale design.

"The success of this partnership is an excellent example of how national laboratories can help fuel industry and drive innovation," said William Brinkman, Director of DOE's Office of Science.

"The Blue Gene supercomputers are an outstanding example of our investment in nuclear security providing the tools to tackle broader national challenges," said NNSA Administrator Thomas D'Agostino. "This machine, which was originally developed to ensure the safety and reliability of our nuclear stockpile without testing, has led to amazing advances in science and discovery. I congratulate IBM, Lawrence Livermore National Laboratory and Argonne National Laboratory for a job well done."

DOE, which leads the world in providing supercomputers for scientific research, began an R&D partnership with IBM in 2001 to develop the Blue Gene platform. Argonne, together with Lawrence Livermore National Laboratory (LLNL), worked on key aspects of the design and provided critical software components to ensure it was well suited to solve challenges in energy, the environment and national security.

"Blue Gene balances energy efficiencies with a major breakthrough in scalability, which is imperative to attack problems in science and engineering at unprecedented scale and speed," said Pete Beckman, director of Argonne's Leadership Computing Facility, home to the first large Blue Gene/P.

The Blue Gene leverages a high-performance, low-power, system-on-a-chip architecture offering extreme integration that dramatically improves reliability, increases energy efficiency and reduces operating costs.

"The Blue Gene architecture has greatly enhanced the National Nuclear Security Administration's capability for predictive simulation and uncertainty quantification," said Mark Seager, Asst. Dept. Head for Advanced Computing Technology at LLNL.

Much of the software needed to operate Blue Gene comes from the open source community and was developed by laboratories and universities around the world. Argonne was actively involved in fostering that community as well as developing key components of the system software. For example, the Blue Gene leverages Argonne's MPICH, the version of the Message Passing Interface that scientists use to write parallel programs capable of scaling to hundreds of thousands of CPU cores. Computer scientists are also working on extending the capabilities of Blue Gene with advanced math libraries, improved parallel file systems, and even experimental operating systems such as ZeptoOS, which permits users to run Linux on the Blue Gene's compute nodes.

Another critical aspect of the Blue Gene's success was ensuring the platform was adopted by the high-performance computing community. In 2004, Argonne and IBM jointly created the Blue Gene Consortium, an international group of laboratory, university and industrial researchers collaborating to evaluate the technology and platform and provide critical feedback for future Blue Gene designs.

The Medal of Technology and Innovation is described as the highest honor for technological achievement for outstanding contributions related to the nation's competiveness, standard of living and quality of life through the development and commercialization of technological products. Obama will present the medal to IBM, as well as four inventors who were also recognized for the award, at a White House ceremony on October 7. The medal program is administered by the United States Patent and Trademark Office and is awarded annually to individuals, teams and companies.

"It is an honor and a privilege to be part of this partnership," said Beckman. "The Blue Gene/P is already making a measurable impact on the research community and enabling advancements that will shape our future".

About Argonne:
The U.S. Department of Energy's Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation's first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America's scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy's Office of Science.

Contact:
Eleanor Taylor
(630) 252-5510

###

Read the full story at http://www.prweb.com/releases/Argonne_Laboratory/IBM_Blue_Gene/prweb3010684.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. MultiVu Video Feed: Easypod(R), Award-Winning Electronic Device
2. Salugens Award-Winning Research on Using DNA Information to Customize Nutritional Supplementation for Weight Loss Presented at the Second Annual Bruce Ames International Symposium on Nutritional Genomics at the University of California, Davis
3. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
4. Perceptum Group Announces New Situational Leadership V Series
5. Agendia Raises US $23 Million in Series E Financing
6. Jennerex Completes Over-Subscribed Series C Financing for Aggregate Gross Proceeds of Over $5.5 Million
7. PharmAbcine Closes USD $6 Million Series A Financing
8. ACD Completes the Second Closing of Series A Financing and Initiates Services for Biomarker Validation and Companion Diagnostic Development
9. Alimera Sciences Closes $5 Million in Extended Series C Financing
10. Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes
11. ProFibrix Raises US $11 Million (EUR 8 million) in Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DOE Labs Take Pride in Award-Winning IBM Blue Gene Series 
(Date:12/2/2016)... ... December 01, 2016 , ... PhUSE will ... the popularity of US Single Day Events (SDE) to organize a multiple-day US ... in Raleigh, NC. Topics of the pharmaceutical and life sciences industry will cover ...
(Date:12/2/2016)... , ... December 02, 2016 ... ... a consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing improved ... interested in supplying a vendor-supported, portable online UHPLC, with robust, probe-based sampling. ...
(Date:12/2/2016)... /PRNewswire/ - bioLytical Laboratories, a world leader in rapid infectious disease tests, introduced the ... Pharmaceutical Association members. (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ... ... , , bioLytical ... (KPA) to introduce the INSTI HIV Self Test to 350 pharmacy representatives in ...
(Date:11/30/2016)... 30, 2016 /PRNewswire/ - Portage Biotech Inc. ("Portage" or ... is excited to announce the formation of EyGen, ... preclinical ophthalmology assets through proof of concept. EyGen,s ... by Portage Pharmaceuticals Limited and being developed for ... and anterior segment diseases. This agent has the ...
Breaking Biology Technology:
(Date:11/21/2016)... Nov. 21, 2016   Neurotechnology , a ... technologies, today announced that the MegaMatcher On Card ... submitted for the NIST Minutiae Interoperability Exchange ... the mandatory steps of the evaluation protocol. ... continuing test of fingerprint templates used to establish ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/22/2016)...  The American College of Medical Genetics and Genomics was ... as one of the fastest-growing trade shows during the Fastest ... in Las Vegas . ... in each of the following categories: net square feet of ... attendees. The 2015 ACMG Annual Meeting was ranked 23 out ...
Breaking Biology News(10 mins):